“showed a trend”

There was no difference between availability and presence data on roads for the Orpen pack (χ 2 1 = 0.33 p = 0.566), but this pack showed a trend for the types of roads utilised (χ 2 9 = 16.04, p = 0.066).

Analysis of the association of serum S100A12 with survival in the whole cohort, including patients with moderate disease, showed a trend to higher levels in non-survivors ( p = 0.066). 4.

SD or its quadratic term were not found to be significant at any time scale, but only showed a trend in the model using daily mean values (daily mean of SD: χ 2 = 3.38, df = 1, P = 0.066, AIC = 1094.2).

As shown in Table 6 , the differences observed in mortality at 6 and 12 months after discharge showed a trend towards statistical significance ( P = .066 and P = .06, respectively).

Furthermore, the SPD +IA group showed a trend towards slower RT than the SPD group (p = .066, d = .65), but the SPD group showed no significant differences from the TDC cohorts (p = .55, d = .23).

In the colon, AI-PCE outperformed CR-PCE in sensitivity (90% vs 68%, p=0.027) and showed a trend towards higher NPV (94% vs 86%, p=0.066), with identical specificity and PPV.

The jejunal villus height (VH) in the 8 mm group showed a trend toward an increase ( p = 0.066), and the ileal crypt depth (CD) was significantly lower ( p = 0.004), with significantly higher digestive enzyme activities in the jejunum and ileum ( p < 0.05).

MMN amplitudes differed over all regions between the ignore and passive task (except P4, all t > 3.00, all p < 0.008, all d > 0.59), and between the ignore and focused task (all t > 2.26, all p < 0.037, all d > 0.52; F3 and F4 showed a trend with both t > 1.96, p < 0.066, d > 0.45).

Consistent with the pressure–volume loop data, echocardiography data showed a trend ( P = 0.066) for an increased FS when compared to intermittent air mice.

At 24 h, the mean improvement in cardiac index from baseline showed a trend in favour of levosimendan over dobutamine (M-W P = 0.066).

Interestingly, diabetes showed a trend toward reduced AAA risk (OR=0.386, 95% CI: 0.140–1.063, P=0.066).

Locoregional recurrence showed a trend toward reduction (3.8% [5/132] vs. 9.4% [31/330], p = 0.066), whereas distant metastasis and overall mortality were similar between groups. 3.4.

Only the PC1 showed a trend to significance ( F 2,835.2 = 2.73, P = 0.066).

CTLA-4 distribution showed a trend of association with a shorter survival ( p = 0.066) although the difference was not statistically significant.

Patients with disease activity higher than the median at golimumab initiation showed a trend to lower retention (p=0.066).

Age showed a trend-level effect - F(1,89) = 3.47, P = .066, η 2 G = 0.30, 95% CI, 0.00;1.00, and including age did not change the pattern of CAPS effects.

As shown in Table 2 , ETP-ALLs showed a trend towards higher chances of positive PI-MRD >0.01% ( p = 0.066) in adult patients and steroid refractoriness (Day +8 blast count) in pediatric patients ( p = 0.056); however, there was no significant difference between different age groups and WHO-defined subgroups in terms of induction failure rates, RFS or OS.

Their findings indicated that PORT significantly improved OS (HR, 0.74; p = 0.021) and showed a trend toward better LRFS (HR, 0.62; p = 0.066) compared to surgery alone.

Although the good‐quality embryo rate was not statistically significant in the two comparisons, it still showed a trend that the flexible GnRH‐ant group was higher than the PPOS group(69.6% vs. 65.9%, p = 0.066) (Table 2 ). 3.3.

Although the M‐TAPA group showed a trend toward reduced nausea incidence ( p = 0.066), other side effects were comparable between groups.

Indeed, although there was not a significant main effect of the valance when considering both tests (T1 and T2), the analysis of T1, which resembles the immediate test used in the mentioned studies, showed a trend for a valence main effect (F 2,72 = 2.826, p = 0.066), with the rate of new responses for the lures that were higher for the neutral pictures compared to negative ( p = 0.037) and positive pictures ( p = 0.051).

Reduced nerve length showed a trend toward association with higher OSS scores ( r = −0.297, p = 0.066).

Positive staining for TDP‐43 showed a trend toward association with lower 1‐year K‐MMSE scores (beta [SE] = −9.45 [4.97], p = 0.066), while α‐synuclein‐positivity was not (beta [SE] = −1.34 [6.05], p = 0.825).

The PPROM group also showed a trend towards a shorter cervical length (2.45 ± 0.79 cm vs. 3.34 ± 0.52 cm, p = 0.066) and lower 1 min and 5 min Apgar scores (median 6.5 vs. 9 and 8.5 vs. 10, respectively), although these differences did not reach statistical significance ( p = 0.114 and 0.093, respectively).

However, on exploratory analyses, the METTL3/ALKBH5 gene expression ratio was predictive of inferior OS (HR =1.052 p= 0.032) and showed a trend towards inferior EFS (HR =1.044 p = 0.066) ( Table 4 B).